Adult
Cefuroxime
Warning
General Information
Do NOT use if patient has a history of severe penicillin allergy. If in doubt, discuss with Micro/ID.
Restricted formulary antimicrobial: For details see OUH netFormulary
AWaRe antibiotic classification: 'Watch'. Use as per guidelines. All other indications to be discussed with Micro/ID.
Renal and hepatic impairment
Renal impairment
eGFR (mL/min/1.73m2) |
IV Dose |
More than 20 |
Dose as in normal renal function |
10-20 |
750mg-1.5g every 12 hours |
Less than 10 |
750mg-1.5g every 24 hours |
HD/HDF/High Flux/PD |
Dose as in eGFR less than 10ml/min/1.73m2. Dialysed; give after dialysis |
Hepatic impairment
No dose adjustment required
Pregnancy and breastfeeding
Pregnancy
Not known to be harmful
Breastfeeding
Present in milk in low concentration but appropriate to use
Additional information
Only IV cefuroxime is on the OUHFT Formulary.
References
- Summary of Product Characteristics (SPC) for Cefuroxime 1.5g Powder for solution for Injection or Infusion. Accessed via www.medicines.org.uk 26/03/18. Last updated 13/06/14
- The Renal Drug Database. Cefuroxime. Accessed via renaldrugdatabase.com 26/03/18. Last updated 21/12/17
- Drugs in Pregnancy and Lactation. Briggs G et al. 6th Edition.